European Medicines Agency (EMA) | What's new Follow Orphan designation: human bispecific monoclonal antibody targeting ALK1 and BMPRII Treatment of hereditary haemorrhagic telangiectasia, 18/07/2025 Positive https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-25-3098 ema.europa.eu
